Affimed to Present at Upcoming Investor Conferences
September 01 2022 - 6:30AM
Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a
clinical-stage immuno-oncology company committed to giving patients
back their innate ability to fight cancer, today announced
that the Company’s management will participate in the following
investor conferences during the month of September 2022.
2022 Wells Fargo Healthcare Conference (September 6-9,
2022)Date: Wednesday, September 7, 2022Presentation Time:
3:10 p.m. Eastern Daylight
TimeWebcast: https://www.affimed.com/investors/webcasts-and-corporate-presentation/
Location: Boston, MA
Citi’s 17th Annual
BioPharma Virtual Conference (September 6-8, 2022)Date:
Thursday, September 8, 2022Only one-on-one meetingsLocation:
Boston, MA
Morgan Stanley’s 20th
Annual Global Healthcare Conference (September 12-14,
2022)Date: Tuesday, September 13, 2022Only one-on-one
meetingsLocation: New York, NY
Jefferies Cell and Genetic Medicine Summit (September
29-30, 2022) Date: Thursday, September 29, 2022Only
one-on-one meetingsLocation: New York, NY
For more information or to schedule a one-on-one meeting with
Affimed’s management, please contact your event representative or
Alex Fudukidis via email at a.fudukidis@affimed.com or phone at +1
(917) 436-8102.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology
company committed to giving patients back their innate ability to
fight cancer. Affimed’s fit-for-purpose ROCK® platform allows
innate cell engagers to be designed for specific patient
populations. The company is developing single and combination
therapies to treat hematologic and solid tumors. The company is
currently enrolling patients into a registration-directed study of
AFM13 for CD30-positive relapsed/refractory peripheral T cell
lymphoma and into a Phase 1/2a dose escalation/expansion study of
AFM24 for the treatment of advanced EGFR-expressing solid tumors.
For more information, please visit www.affimed.com.
Affimed Investor Contact
Alexander FudukidisDirector, Investor
RelationsE-Mail: a.fudukidis@affimed.comTel.: +1 (917)
436-8102
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2023 to Apr 2024